Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroids in IgA Nephropathy with Active Pathological Changes
NCT02160132Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jun 2014
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone injection in IgA nephropathy (IgAN), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
methylprednisolone injection
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT02160132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02160132.